vs

Side-by-side financial comparison of CAPITAL CITY BANK GROUP INC (CCBG) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

CAPITAL CITY BANK GROUP INC is the larger business by last-quarter revenue ($63.5M vs $37.2M, roughly 1.7× Organogenesis Holdings Inc.). On growth, CAPITAL CITY BANK GROUP INC posted the faster year-over-year revenue change (6.0% vs -57.1%). Over the past eight quarters, CAPITAL CITY BANK GROUP INC's revenue compounded faster (6.0% CAGR vs -46.5%).

Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CCBG vs ORGO — Head-to-Head

Bigger by revenue
CCBG
CCBG
1.7× larger
CCBG
$63.5M
$37.2M
ORGO
Growing faster (revenue YoY)
CCBG
CCBG
+63.1% gap
CCBG
6.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
CCBG
CCBG
Annualised
CCBG
6.0%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCBG
CCBG
ORGO
ORGO
Revenue
$63.5M
$37.2M
Net Profit
$13.7M
Gross Margin
30.8%
Operating Margin
29.3%
-185.1%
Net Margin
21.6%
Revenue YoY
6.0%
-57.1%
Net Profit YoY
4.7%
EPS (diluted)
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCBG
CCBG
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$63.5M
$225.6M
Q3 25
$65.9M
$150.9M
Q2 25
$63.2M
$101.0M
Q1 25
$61.5M
$86.7M
Q4 24
$59.9M
$126.7M
Q3 24
$59.7M
$115.2M
Q2 24
$58.9M
$130.2M
Net Profit
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
$13.7M
$43.7M
Q3 25
$15.9M
$21.6M
Q2 25
$15.0M
$-9.4M
Q1 25
$16.9M
$-18.8M
Q4 24
$13.1M
$7.7M
Q3 24
$13.1M
$12.3M
Q2 24
$14.2M
$-17.0M
Gross Margin
CCBG
CCBG
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
CCBG
CCBG
ORGO
ORGO
Q1 26
-185.1%
Q4 25
29.3%
28.1%
Q3 25
32.0%
13.7%
Q2 25
31.7%
-12.5%
Q1 25
35.8%
-30.9%
Q4 24
29.0%
8.1%
Q3 24
26.1%
5.4%
Q2 24
29.3%
-10.7%
Net Margin
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
21.6%
19.4%
Q3 25
24.2%
14.3%
Q2 25
23.8%
-9.3%
Q1 25
27.4%
-21.7%
Q4 24
21.9%
6.1%
Q3 24
22.0%
10.7%
Q2 24
24.0%
-13.1%
EPS (diluted)
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
$0.80
$0.31
Q3 25
$0.93
$0.11
Q2 25
$0.88
$-0.10
Q1 25
$0.99
$-0.17
Q4 24
$0.78
$0.05
Q3 24
$0.77
$0.09
Q2 24
$0.83
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCBG
CCBG
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$552.9M
Total Assets
$4.4B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCBG
CCBG
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
$552.9M
$300.1M
Q3 25
$540.6M
$255.1M
Q2 25
$526.4M
$233.2M
Q1 25
$512.6M
$242.9M
Q4 24
$495.3M
$262.9M
Q3 24
$476.5M
$278.5M
Q2 24
$461.0M
$263.5M
Total Assets
CCBG
CCBG
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$4.4B
$598.7M
Q3 25
$4.3B
$509.8M
Q2 25
$4.4B
$461.1M
Q1 25
$4.5B
$467.4M
Q4 24
$4.3B
$497.9M
Q3 24
$4.2B
$446.3M
Q2 24
$4.2B
$443.2M
Debt / Equity
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCBG
CCBG
ORGO
ORGO
Operating Cash FlowLast quarter
$87.6M
Free Cash FlowOCF − Capex
$80.0M
FCF MarginFCF / Revenue
126.1%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
6.39×
TTM Free Cash FlowTrailing 4 quarters
$150.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
$87.6M
$39.4M
Q3 25
$21.6M
$3.1M
Q2 25
$32.6M
$-32.9M
Q1 25
$21.9M
$-19.9M
Q4 24
$63.6M
$10.9M
Q3 24
$12.8M
$8.7M
Q2 24
$24.9M
$4.7M
Free Cash Flow
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
$80.0M
$34.8M
Q3 25
$19.8M
$844.0K
Q2 25
$30.8M
$-36.5M
Q1 25
$19.5M
$-23.6M
Q4 24
$54.9M
$7.6M
Q3 24
$10.5M
$6.1M
Q2 24
$23.0M
$2.9M
FCF Margin
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
126.1%
15.4%
Q3 25
30.1%
0.6%
Q2 25
48.7%
-36.1%
Q1 25
31.7%
-27.2%
Q4 24
91.7%
6.0%
Q3 24
17.6%
5.3%
Q2 24
39.0%
2.2%
Capex Intensity
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
12.0%
2.1%
Q3 25
2.6%
1.5%
Q2 25
2.9%
3.6%
Q1 25
3.9%
4.2%
Q4 24
14.5%
2.7%
Q3 24
3.8%
2.2%
Q2 24
3.3%
1.4%
Cash Conversion
CCBG
CCBG
ORGO
ORGO
Q1 26
Q4 25
6.39×
0.90×
Q3 25
1.35×
0.14×
Q2 25
2.17×
Q1 25
1.30×
Q4 24
4.86×
1.43×
Q3 24
0.97×
0.71×
Q2 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons